Statistics
Publications
2
Citations
55
H-Index
2
Active since
2018
Bo Kang is an author at First Affiliated Hospital of Harbin Medical University specializing in molecular oncology, medicine, and oncology.
Publications per year
2018–2019
2
2
UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma
Hao Peng, Bo Kang, Yapeng Li et al. · Molecular Medicine Reports · 2019 · 39 citations · Full text
Medicine, Cell Biology, Oncology +17
MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC
Hao Peng, Bo Kang, Guoqing Yao et al. · Oncology Letters · 2018 · 16 citations · Full text
1–2 of 2